Targeted protein degradation in the pathogenesis and therapy of multiple myeloma
- Weitere Titel
-
Gezielte Proteindegradation in der Pathogenese und Therapie des Multiplen Myeloms
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Berlin, Medizinische Fakultät Charité - Universitätsmedizin Berlin, Dissertation, 2025
- Schlagwort
-
Targeted drug delivery
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Medizinische Fakultät Charité - Universitätsmedizin Berlin
- (wann)
-
2025
- Urheber
-
Ng, Yuen Lam Dora
- DOI
-
10.17169/refubium-45716
- URN
-
urn:nbn:de:kobv:188-refubium-46006-6
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ng, Yuen Lam Dora
- Medizinische Fakultät Charité - Universitätsmedizin Berlin
Entstanden
- 2025
Ähnliche Objekte (12)
Multiple Myeloma: Molecular Pathogenesis and Disease Evolution
BCMA-targeted immunotherapy for multiple myeloma
Multiple myeloma: signaling pathways and targeted therapy
Pathogenesis of bone disease in multiple myeloma: from bench to bedside
Roles of miRNA dysregulation in the pathogenesis of multiple myeloma
Targeted immunotherapy: harnessing the immune system to battle multiple myeloma
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Multiple myeloma
Glutaminase inhibition in multiple myeloma induces apoptosis via MYC degradation
The role of JunB in multiple myeloma pathogenesis: focus on angiogenesis
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis
Sequential CAR T cell and targeted alpha immunotherapy in disseminated multiple myeloma
Multiple Myeloma: Molecular Pathogenesis and Disease Evolution
BCMA-targeted immunotherapy for multiple myeloma
Multiple myeloma: signaling pathways and targeted therapy
Pathogenesis of bone disease in multiple myeloma: from bench to bedside
Roles of miRNA dysregulation in the pathogenesis of multiple myeloma
Targeted immunotherapy: harnessing the immune system to battle multiple myeloma
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Multiple myeloma
Glutaminase inhibition in multiple myeloma induces apoptosis via MYC degradation
The role of JunB in multiple myeloma pathogenesis: focus on angiogenesis
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis
Sequential CAR T cell and targeted alpha immunotherapy in disseminated multiple myeloma
Multiple Myeloma: Molecular Pathogenesis and Disease Evolution
BCMA-targeted immunotherapy for multiple myeloma
Multiple myeloma: signaling pathways and targeted therapy
Pathogenesis of bone disease in multiple myeloma: from bench to bedside
Roles of miRNA dysregulation in the pathogenesis of multiple myeloma
Targeted immunotherapy: harnessing the immune system to battle multiple myeloma
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Multiple myeloma
Glutaminase inhibition in multiple myeloma induces apoptosis via MYC degradation
The role of JunB in multiple myeloma pathogenesis: focus on angiogenesis
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis